• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses

tetano

Editor, Senior Moderator
Nat Commun


. 2021 Sep 17;12(1):5498.
doi: 10.1038/s41467-021-25729-7.
A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses


Joep Beumer[SUP] #[/SUP][SUP] 1 [/SUP], Maarten H Geurts[SUP] #[/SUP][SUP] 1 [/SUP], Mart M Lamers[SUP] #[/SUP][SUP] 2 [/SUP], Jens Puschhof[SUP] 1 [/SUP], Jingshu Zhang[SUP] 2 [/SUP], Jelte van der Vaart[SUP] 1 [/SUP], Anna Z Mykytyn[SUP] 2 [/SUP], Tim I Breugem[SUP] 2 [/SUP], Samra Riesebosch[SUP] 2 [/SUP], Debby Schipper[SUP] 2 [/SUP], Petra B van den Doel[SUP] 2 [/SUP], Wim de Lau[SUP] 1 [/SUP], Cayetano Pleguezuelos-Manzano[SUP] 1 [/SUP], Georg Busslinger[SUP] 1 [/SUP], Bart L Haagmans[SUP] 3 [/SUP], Hans Clevers[SUP] 4 [/SUP]



Affiliations
Free article

Abstract

Rapid identification of host genes essential for virus replication may expedite the generation of therapeutic interventions. Genetic screens are often performed in transformed cell lines that poorly represent viral target cells in vivo, leading to discoveries that may not be translated to the clinic. Intestinal organoids are increasingly used to model human disease and are amenable to genetic engineering. To discern which host factors are reliable anti-coronavirus therapeutic targets, we generate mutant clonal IOs for 19 host genes previously implicated in coronavirus biology. We verify ACE2 and DPP4 as entry receptors for SARS-CoV/SARS-CoV-2 and MERS-CoV respectively. SARS-CoV-2 replication in IOs does not require the endosomal Cathepsin B/L proteases, but specifically depends on the cell surface protease TMPRSS2. Other TMPRSS family members were not essential. The newly emerging coronavirus variant B.1.1.7, as well as SARS-CoV and MERS-CoV similarly depended on TMPRSS2. These findings underscore the relevance of non-transformed human models for coronavirus research, identify TMPRSS2 as an attractive pan-coronavirus therapeutic target, and demonstrate that an organoid knockout biobank is a valuable tool to investigate the biology of current and future emerging coronaviruses.
 
Back
Top Bottom